In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lipocine Inc.

www.lipocine.com

Latest From Lipocine Inc.

Keeping Track: Resubmissions For Tlando And Twirla NDAs, And A BTD For Pomalyst

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Pediatric Testosterone Therapy: Sponsors Wary Of Trials Despite PREA

Studies are unfeasible, sponsors argue in advance of US advisory committee meeting that could lead to FDA ending its waiver on requiring clinical trials in pediatric patients for new testosterone replacement therapy products.
Advisory Committees Clinical Trials

Keeping Track: Approvals For Mayzent, Mavenclad, Duaklir, Jatenzo And Cimzia

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Regulation

Clarus Keeping Commercial Options Open For Oral Testosterone Jatenzo

Jatenzo – the first oral testosterone cleared by US FDA – will compete against injectable and topical formulas in a field that has suffered safety worries in the past. Clarus has a jump on oral rival Lipocine.

Approvals Launches
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Lipocine Inc.
  • Senior Management
  • Mahesh V Patel, PhD, Pres. & CEO
    Morgan Brown, EVP, CFO
    Anthony Delconte, MD, CMO
    Gregory Bass, Chief Commercial Officer
  • Contact Info
  • Lipocine Inc.
    Phone: (801) 994-7383
    675 Arapeen Dr.
    Ste. 202
    Salt Lake City, UT 84108
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register